Affinia News

Key Points Biologics are large molecule products, such as proteins or monoclonal antibodies, with inherent variations that make them impossible to replicate. Biosimilars are defined by the FDA as “biological products that are highly similar to and have no clinically meaningful differences from an existing...
Read More
Key Points Not all ranitidine products have been recalled at this time. Updates on recalled ranitidine products can be found online here. Patients who wish to discontinue ranitidine should talk with a healthcare provider about alternative treatment options before switching The FDA is currently testing...
Read More
Heart failure documentation must include the following key elements: 1. Type of heart failure Diastolic Systolic Combined Diastolic and Systolic Note: Documentation of Systolic and/or Diastolic Dysfunction does not equate to the type of heart failure. Heart failure and dysfunction are not interchangeable terms; documentation...
Read More
Key Points Drug approval is a costly and extensive process. Trials for drug approval include animal studies, safety studies, efficacy studies, and post-marketing research. A large number of drugs have gained new approvals in 2019. Some of the categories of these drugs include those within...
Read More
Save the Date: October 26, 2019 at 10am-2pm Key Points National Prescription Drug Take Back Day occurs twice annually (usually in April and October). The next Drug Take Back Day will occur on October 26, 2019. Drug take back events are important for public health...
Read More
1 2 3 4 8

Upcoming Events

Apr 23

Affinia Health Network Annual Conference

April 23 @ 8:00 am - 4:30 pm